Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Mar
3
2023
 DEA Proposes Limited Post-PHE Telemedicine Prescription of Controlled Substances McDermott Will & Emery
Mar
2
2023
 The Health AI Frontier: New Opportunities for Innovation Across the Health Care Sector Foley & Lardner LLP
Mar
2
2023
 FDA Withdraws Proposed Rule on General Principles for Food Standards Modernization Keller and Heckman LLP
Mar
2
2023
 Consumer Fraud PFAS Cases Continue To Rise CMBG3 Law
Mar
1
2023
 North Carolina Senate Passes Compassionate Care Act – at Exactly 4:20 p.m.
Mar
1
2023
 Desperate Times, Desperate Measuring Cups – FTC Brings Enforcement Action for False “Made in USA” Advertising ArentFox Schiff LLP
Mar
1
2023
 Unpacking Averages: Exploring New Data on FDA Responses to FOIA Requests Epstein Becker & Green, P.C.
Feb
28
2023
 FDA Asked to Allow “Healthy” Claims on Coffee Keller and Heckman LLP
Feb
28
2023
 China Announces Draft Standard on Nutritional Fortification Substances: What Will its Impact Be on Alternative Protein Foods? Keller and Heckman LLP
Feb
28
2023
 Will the U.S. Supreme Court Make Marijuana Legal? Bradley Arant Boult Cummings LLP
Feb
28
2023
 This Week in 340B: February 21 – 27, 2023 McDermott Will & Emery
Feb
27
2023
 Old North State Report – Feb. 27, 2023 Nelson Mullins
Feb
27
2023
 FDA Publishes List of 2023 Priority Guidance Topics Keller and Heckman LLP
Feb
27
2023
 DEA Announces Permanent Flexibilities for the Prescribing of Controlled Substances via Telemedicine Polsinelli PC
Feb
27
2023
 DEA’s Proposed Rules on Telemedicine Controlled Substances Prescribing after the PHE Ends Foley & Lardner LLP
Feb
25
2023
 No Surprises Act Update: Certified IDR Entities to Resume Payment Determinations for Services Furnished Before October 25, 2022 Sheppard, Mullin, Richter & Hampton LLP
Feb
25
2023
 HHS-OIG Declines to Impose Sanctions on Drug Manufacturer for Financial Assistance to Pediatric Patients with Rare Disease Barnes & Thornburg LLP
Feb
24
2023
 Cosmetics – Moving From Voluntary Compliance to Mandatory Regulation Beveridge & Diamond PC
Feb
24
2023
 From the Year of the Tiger to the Year of the Rabbit Keller and Heckman LLP
Feb
24
2023
 FDA Files Civil Money Penalty Complaints Against Four Small Vape Shops for Alleged Premarket Review Violations Keller and Heckman LLP
Feb
24
2023
 Tenth Circuit Declares No Remedy for Hemp Farmer Whose Federally Legal Plants Were Seized ArentFox Schiff LLP
Feb
24
2023
 FDA Releases Draft Guidance on Labeling of Plant-Based Milk Alternatives Keller and Heckman LLP
Feb
23
2023
 Coverage for Rotten Eggs: Livestock Coverage in the Event of a Crisis Hunton Andrews Kurth
Feb
23
2023
 Modified REMS, Clarification on Mailing Drugs, and Movement in Texas Case Mark Significant Weeks in the Reproductive Health Legal Sphere ArentFox Schiff LLP
Feb
23
2023
 THC-Oh No! The DEA Classifies Delta-8 and Delta-9 THCO as Controlled Substances
Feb
23
2023
 Walking the Highwire of Affiliate Marketing and Advertising Claims [PODCAST] Greenberg Traurig, LLP
Feb
22
2023
 CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs Sheppard, Mullin, Richter & Hampton LLP
Feb
21
2023
 Lawsuit Alleges PFAS in Pomegranate Juice Keller and Heckman LLP
Displaying 2437 - 2464 of 12182
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters